Education
About Us
Working with TipRanks
Follow Us
Forte Biosciences Inc. (FBRX)
NASDAQ:FBRX
Fb102
Alopecia Areata
Phase I
Not Yet Recruiting
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Sep 25, 2025
―
Fb102
Celiac Disease
Phase II
Recruiting
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
May 13, 2025
―
Fb102
Vitiligo
Phase I
Recruiting
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Mar 11, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Forte Biosciences Inc. (FBRX) have in its pipeline
FBRX is currently developing the following drugs: Fb102, Fb102, Fb102. These drug candidates are in various stages of clinical development as the company works toward FDA approval.